Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance

Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study

Editor's choice for December 2015

Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging

Novel estrogen receptor-targeting agent represents ‘quantum leap’

Ductal carcinoma in situ: Anastrozole versus tamoxifen

Update on management of the axilla

Higher local recurrence after skin-sparing than simple mastectomy for DCIS

Peri-operative lapatinib has profound antiproliferative effect in early breast cancer

Guidelines and management of advanced breast cancer in limited resource settings